CSIMarket
 


Biogen Inc   (BIIB)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

BIIB's Operating Income Growth by Quarter and Year

Biogen Inc 's Operating Income results by quarter and year




BIIB Operating Income (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
IV Quarter December -330.70 1,777.70 1,443.10 1,465.80
III Quarter September 1,086.40 1,806.30 1,697.60 1,653.50
II Quarter June 1,974.50 1,955.90 1,213.20 1,200.60
I Quarter March 1,819.90 1,502.70 1,534.70 1,024.30
FY   4,550.10 7,042.60 5,888.60 5,344.20



BIIB Operating Income forth quarter 2020 Y/Y Growth Comment
Biogen Inc in the forth quarter recorded Operating Loss of $ -330.70 millions.

Among companies who have reported forth quarter results in the Biotechnology & Drugs industry only one Company has achieved higher year on year Operating Income results in the forth quarter. While Biogen Inc ' s Operating Income no change of % ranks overall at the positon no. 179 in the forth quarter.

Explain Operating Income growth


BIIB Operating Income ( Y/Y Growth %) 2020
2019 2018 2017
IV Quarter December - 23.19 % -1.55 % 65.4 %
III Quarter September -39.85 % 6.4 % 2.67 % 16.01 %
II Quarter June 0.95 % 61.22 % 1.05 % -17.8 %
I Quarter March 21.11 % -2.09 % 49.83 % -25.69 %
FY   -35.39 % 19.6 % 10.19 % 3.76 %

Financial Statements
Biogen Inc 's forth quarter 2020 Operating Income $ -330.70 millions BIIB's Income Statement
Biogen Inc 's forth quarter 2019 Operating Income $ 1,777.70 millions Quarterly BIIB's Income Statement
New: More BIIB's historic Operating Income Growth >>


BIIB Operating Income (Quarter on Quarter Growth %)

2020
2019 2018 2017
IV Quarter December - -1.58 % -14.99 % -11.35 %
III Quarter September -44.98 % -7.65 % 39.93 % 37.72 %
II Quarter June 8.49 % 30.16 % -20.95 % 17.21 %
I Quarter March 2.37 % 4.13 % 4.7 % 15.58 %
FY (Year on Year)   -35.39 % 19.6 % 10.19 % 3.76 %




Operating Income forth quarter 2020 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #2
Healthcare Sector #14
Overall #179

Operating Income Y/Y Growth Statistics
High Average Low
106.48 % 6.52 % -50.43 %
(Sep. 30, 2006)   (June 30. 2006)
Operating Income forth quarter 2020 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #2
Healthcare Sector #14
Overall #179
Operating Income Y/Y Growth Statistics
High Average Low
106.48 % 6.52 % -50.43 %
(Sep. 30, 2006)   (June 30. 2006)

Operating Income by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Biogen Inc 's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


BIIB's IV. Quarter Q/Q Operating Income Comment
IV. Quarter 2020 Operating Loss of -330.70 millions by Biogen Inc appear even worse if you take a look at 1,086.40 millions in the third quarter.

Within Biotechnology & Drugs industry Biogen Inc achieved highest sequential Operating Income growth. While Biogen Inc 's Operating Income growth quarter on quarter, overall rank is .


Operating Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


BIIB's IV. Quarter Q/Q Operating Income Comment
Recent accomplishment of -330.70 millions by Biogen Inc look even more unfavourable compare to the 1,086.40 millions a quarter before.

Within Biotechnology & Drugs industry Biogen Inc achieved highest sequential Operating Income growth. While Biogen Inc 's Operating Income growth quarter on quarter, overall rank is .


Biogen Inc 's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Dec 31 2020)
12 Months Ending
(Sep 30 2020)
12 Months Ending
(Jun 30 2020)
12 Months Ending
(Mar 31 2020)
12 Months Ending
(Dec 31 2019)
Cumulative Operating Income 12 Months Ending $ 4,550.10 $ 6,658.50 $ 7,378.40 $ 7,359.80 $ 7,042.60
Y / Y Operating Income Growth (TTM) -35.39 % -0.74 % 11.81 % 25.67 % 19.6 %
Year on Year Operating Income Growth Overall Ranking # 146 # 912 # 663 # 626 # 101
Seqeuential Operating Income Change (TTM) -31.66 % -9.76 % 0.25 % 4.5 % 4.99 %
Seq. Operating Income Growth (TTM) Overall Ranking # 1107 # 1662 # 946 # 611 # 304




Cumulative Operating Income growth Comment
Biogen Inc 's cumulative 12 months Operating Income continue to drop, but on the faster rate at -35.39% year on year, at Dec 31 2020 compare to the -0.74% decrease at Sep 30 2020. If the Biogen Inc 's fiscal year would end at Dec 31 2020, annual Operating Income would be $4,550 millions.

Among companies within the Healthcare sector 12 other companies have achieved higher trailing twelve month Operating Income growth. While Total ranking has impoved so far to 146, from total ranking in previous quarter at 912.

Operating Income TTM Q/Q Growth Statistics
High Average Low
106.48 %
6.52 %
-50.43 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry # 15
Healthcare Sector # 13
Overall # 146

Operating Income TTM Y/Y Growth Statistics
High Average Low
443.68 %
37.96 %
-35.39 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 15
Sector # 96
S&P 500 # 1107
Cumulative Operating Income growth Comment
Biogen Inc 's cumulative 12 months Operating Income continue to drop, but on the faster rate at -35.39% year on year, at Dec 31 2020 compare to the -0.74% decrease at Sep 30 2020. If the Biogen Inc 's fiscal year would end at Dec 31 2020, annual Operating Income would be $4,550 millions.

Among companies within the Healthcare sector 12 other companies have achieved higher trailing twelve month Operating Income growth. While Total ranking has impoved so far to 146, from total ranking in previous quarter at 912.

Operating Income TTM Q/Q Growth Statistics
High Average Low
106.48 %
6.52 %
-50.43 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry # 15
Healthcare Sector # 13
Overall # 146

Operating Income TTM Y/Y Growth Statistics
High Average Low
443.68 %
37.96 %
-35.39 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 15
Sector # 96
S&P 500 # 1107




Other Operating Income Growth
Biotechnology & Drugs Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
BIIB's Operating Income Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for BIIB's Competitors
Operating Income Growth for Biogen Inc 's Suppliers
Operating Income Growth for BIIB's Customers

You may also want to know
BIIB's Annual Growth Rates BIIB's Profitability Ratios BIIB's Asset Turnover Ratio BIIB's Dividend Growth
BIIB's Roe BIIB's Valuation Ratios BIIB's Financial Strength Ratios BIIB's Dividend Payout Ratio
BIIB's Roa BIIB's Inventory Turnover Ratio BIIB's Growth Rates BIIB's Dividend Comparisons



Companies with similar Operating Income drop for the quarter ending Dec 31 2020 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Dec 31 2020
Check cap Ltd-0.97%$ -0.974 millions
Haemonetics Corp-1.18%$ -1.178 millions
Prestige Consumer Healthcare Inc -3.88%$ -3.875 millions
Pra Health Sciences inc -4.22%$ -4.219 millions
Fonar Corp-4.36%$ -4.361 millions
Amgen Inc -5.53%$ -5.530 millions
Henry Schein Inc-7.71%$ -7.708 millions
Utah Medical Products Inc-8.51%$ -8.506 millions
Orthofix Medical Inc -9.52%$ -9.524 millions
Icon Plc-9.67%$ -9.669 millions
Encompass Health Corporation-10.41%$ -10.413 millions
Align Technology inc -10.75%$ -10.746 millions
Conmed Corporation-11.40%$ -11.399 millions
Radnet Inc -12.06%$ -12.064 millions
Corcept Therapeutics Inc-12.86%$ -12.861 millions
National Research Corporation-14.84%$ -14.839 millions
Kamada Ltd-15.57%$ -15.568 millions
Diversicare Healthcare Services Inc -15.76%$ -15.763 millions
Taro Pharmaceutical Industries Ltd-16.77%$ -16.765 millions
Davita Inc -17.49%$ -17.492 millions
Stryker Corp-20.66%$ -20.657 millions
Infusystem Holdings Inc-21.05%$ -21.053 millions
Genesis Healthcare Inc -21.41%$ -21.413 millions
National Healthcare Corp-22.54%$ -22.537 millions
Baxter International Inc -23.40%$ -23.396 millions
Pacific Health Care Organization Inc-23.89%$ -23.893 millions
Teleflex Incorporated-25.09%$ -25.094 millions
Healthcare Services Group Inc -25.61%$ -25.611 millions
Collplant Biotechnologies Ltd-26.63%$ -26.628 millions
Zimmer Biomet Holdings Inc -28.53%$ -28.533 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

ADMEN's Profile

Stock Price

ADMEN's Financials

Business Description

Fundamentals

Charts & Quotes

ADMEN's News

Suppliers

ADMEN's Competitors

Customers & Markets

Economic Indicators

ADMEN's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071